OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
General Information	289
Intrafamilial Correlation and Variability in the Clinical Evolution of Pulmonary Fibrosis	280
General Information	186
Response	164
General Information	146
A 51-Year-Old Man With Dyspnea and a Pulmonary Nodule	137
The Proton Is Not Enough	130
Attic of Sorrow	108
A 36-Year-Old Patient With Crohn Disease and Bilateral Pleural Effusions	106
“Suction vs Gravity: A Distinction Without a Difference?”	105
Unraveling the Healthy Adherer Effect in the Clinical Management of Sleep Apnea With CPAP	103
Radiomic Signatures in COPD	100
CLINICAL IMPACT OF SGLT2 INHIBITORS AND EUGLYCEMIC DIABETIC KETOACIDOSIS: INSIGHTS FROM THE FAERS DATABASE	100
Inhaled Corticosteroids in COPD and Bronchiectasis	99
Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosis	95
Response	89
Refining the Lung Allocation Score Models Fails to Improve Discrimination Performance	88
A Mediastinal Mass in a Middle-Aged Woman From a Rare Cause	87
Pulmonary Artery Calcification in a 57-Year-Old Man	87
COVID-19 MYOCARDITIS MIMICKING ACS	86
Rebuttal From Dr Keir and Prof Chalmers	83
WITHDRAWN	83
WITHDRAWN	81
HEMOTHORAX SECONDARY TO THORACIC ENDOMETRIOSIS	80
DISSEMINATED CRYPTOCOCCAL INFECTION AFTER INITIATION OF BENRALIZUMAB IN A PATIENT WITH ASYMPTOMATIC PULMONARY CRYPTOCOCCUS	78

KETAMINE TO ASSIST VENTILATOR WEANING AND EXTUBATION IN PATIENTS WHO FAIL SBT FROM SEVERE AGITATION AND ANXIETY	78
COVID-ASSOCIATED PULMONARY FIBROSIS: SUBPLEURAL SPARING DISTANCE AS A DISTINGUISHING FEATURE COMPARED TO NON-COVID NONSPECIFIC INTERSTITIAL PNEUMONIA	77
MASSIVE EMPYEMA SECONDARY TO STREPTOCOCCUS CONSTELLATUS INFECTION	76
THE CASCADING EFFECT: A RARE CASE OF EPINEPHRINE-INDUCED CORONARY ARTERY VASOSPASM	72
A CHALLENGING DIAGNOSIS OF MULTIPLE PULMONARY NODULES IN AN IMMUNOSUPPRESSED PATIENT WITH APLASTIC ANEMIA WITH CYTOPENIAS: A CASE REPORT	70
TURNING OF THE TIDES, WHEN BENIGN BECOMES MALIGNANT: A CASE OF LARGE FIBROUS TUMOR OF THE LUNG	70
AN UNUSUAL PRESENTATION OF A PULSATILE NECK MASS	69
PROCEDURAL GUIDANCE FOR EXTRACORPOREAL MEMBRANE OXYGENATION WITH TRANSESOPHAGEAL ULTRASOUND	68
A CASE OF AN ATYPICAL ENDOBROCHIAL LESION	66
Monitoring Biologic Therapy in Asthma Using Functional Imaging	66
WITHDRAWN	65
WHEN YOU HEAR HOOFBEATS, PREPARE FOR ZEBRAS: A CASE OF SARCOMATOID CARCINOMA	65
PATHOPHYSIOLOGY OF LACTIC ACIDOSIS IN PATIENTS WITH ASTHMA	65
ISCHEMIC CEREBROVASCULAR SYNDROME, THE DEBUT OF A NEPHROTIC SYNDROME	64
NONISCHEMIC CARDIOMYOPATHY AND CARDIAC ARREST ATTRIBUTABLE TO ANABOLIC-ANDROGENIC STEROIDS	64
STREPTOCOCCUS AGALACTIAE ENDOCARDITIS OF THE NATIVE VALVE IN THE PATIENT WITH END-STAGE RENAL DISEASE	62
OBSTRUCTIVE LUNG DISEASE CONCORDANCE/DISCORDANCE WHEN COMPARING TWO PREDICTIVE EQUATIONS (GLI VS CRAPO/MORRIS)	62
CHRONIC MYELOID LEUKEMIA COMPLICATED WITH BILATERAL PLEURAL EFFUSIONS SECONDARY TO BOSUTINIB	61
IBRUTINIB-INDUCED SINUS NODE DYSFUNCTION: A RARE CLINICAL ENTITY	60
CHANGES IN FRACTION OF EXHALED NITRIC OXIDE WHILE VAPING E-CIGERETTE	60
INCIDENCE, CLINICAL CHARACTERISTICS, AND OUTCOMES OF PATIENTS WITH COVID-19 AND FUNGAL COINFECTION	59
AMINOPHYLLINE: A FORGOTTEN RESCUE AGENT FOR PATIENTS WITH SEVERE COPD EXACERBATION AND RIGHT HEART FAILURE? A CASE REPORT AND REVIEW OF THE LITERATURE	59
A UNIQUE CASE OF GRANULOMATOSIS WITH POLYANGIITIS COMPLICATED BY THROMBOTIC THROMBOCYTOPENIA PURPURA	59
DIFFUSE ALVEOLAR HEMORRHAGE SECONDARY TO FENTANYL INHALATION	58
WITHDRAWN	58
NONCONVULSIVE STATUS EPILEPTICUS: AN IMPORTANT PRESENTATION OF CEFEPIME-INDUCED NEUROTOXICITY	57
ACUTE PULMONARY EMBOLISM IN PATIENTS WITH UNDERLYING PULMONARY HYPERTENSION	57
MASSIVE PULMONARY EMBOLISM IN COVID-19 PNEUMONIA DIAGNOSED WITH POCUS	57
A QUALITY IMPROVEMENT INITIATIVE TO INCREASE APPROPRIATENESS OF REFERRALS FOR PULMONARY FUNCTION TESTING	54
COMMONLY USED MAGNESIUM SULFATE UNCOMMONLY CAUSING PULMONARY EDEMA	54